Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances

Overview

Journal Clin J Am Soc Nephrol

Specialty Nephrology

Date 2011 Mar 19

PMID 21415315

Citations 32

Authors

Bertrand L Jaber

Brigitte Schiller

John M Burkart

Rachid Daoui

Michael A Kraus

Yoojin Lee

Brent W Miller

Isaac Teitelbaum

Amy W Williams

Fredric O Finkelstein

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Restless legs syndrome (RLS) and sleep disturbances are common among in-center hemodialysis patients and are associated with increased morbidity/mortality.

Design, Setting, Participants, & Measurements: The FREEDOM study is an ongoing prospective cohort study investigating the benefits of home short daily hemodialysis (SDHD) (6 times/week). In this interim report, we examine the long-term effect of SDHD on the prevalence and severity of RLS, as measured by the International Restless Legs Syndrome (IRLS) Study Group rating scale, and sleep disturbances, as measured by the Medical Outcomes Study sleep survey.

Results: 235 participants were included in this report (intention-to-treat cohort), of which 127 completed the 12-month follow-up (per-protocol cohort). Mean age was 52 years, 55% had an arteriovenous fistula, and 40% suffered from RLS. In the per-protocol analysis, among patients with RLS, the mean IRLS score improved significantly at month 12, after adjustment for use of RLS-related medications (18 versus 11). Among patients with moderate-to-severe RLS (IRLS score ≥15), there was an even greater improvement in the IRLS score (23 versus 13). The intention-to-treat analysis yielded similar results. Over 12 months, there was decline in the percentage of patients reporting RLS (35% versus 26%) and those reporting moderate-to-severe RLS (59% versus 43%). There was a similar and sustained 12-month improvement in several scales of the sleep survey, after adjustment for presence of RLS and use of anxiolytics and hypnotics.

Conclusions: Home SDHD is associated with long-term improvement in the prevalence and severity of RLS and sleep disturbances.

Citing Articles

Home versus in-centre haemodialysis for people with kidney failure.

Cheetham M, Ethier I, Krishnasamy R, Cho Y, Palmer S, Johnson D Cochrane Database Syst Rev. 2024; 4:CD009535.

PMID: 38588450 PMC: 11001293. DOI: 10.1002/14651858.CD009535.pub3.

Exploring the impact of short daily haemodialysis on muscle strength and bone health in end-stage kidney disease patients.

Tavares F, de Luca Correa H, Wilund K, Deus L, de Araujo T, Tzanno-Martins C J Cachexia Sarcopenia Muscle. 2024; 15(2):718-725.

PMID: 38272859 PMC: 10995248. DOI: 10.1002/jcsm.13428.

Patient Survival With Extended Home Hemodialysis Compared to In-Center Conventional Hemodialysis.

Ok E, Demirci C, Asci G, Yuksel K, Kircelli F, Koc S Kidney Int Rep. 2023; 8(12):2603-2615.

PMID: 38106580 PMC: 10719649. DOI: 10.1016/j.ekir.2023.09.007.

Efficacy and safety of acupuncture on insomnia in maintenance hemodialysis patients: A randomized clinical trial protocol.

Wang P, Wang Z, Li Z, Ma S, Li Y, Li H Contemp Clin Trials Commun. 2023; 35:101196.

PMID: 37583470 PMC: 10423895. DOI: 10.1016/j.conctc.2023.101196.

Five Things to Know About Restless Legs Syndrome in Patients on Dialysis.

Prasad B, Gagarinova M, Sharma A Can J Kidney Health Dis. 2023; 10:20543581231164275.

PMID: 36994129 PMC: 10041586. DOI: 10.1177/20543581231164275.

References

Culleton B, Walsh M, Klarenbach S, Mortis G, Scott-Douglas N, Quinn R . Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007; 298(11):1291-9. DOI: 10.1001/jama.298.11.1291. View

Gigli G, Adorati M, Dolso P, Piani A, Valente M, Brotini S . Restless legs syndrome in end-stage renal disease. Sleep Med. 2004; 5(3):309-15. DOI: 10.1016/j.sleep.2004.01.014. View

Takaki J, Nishi T, Shimoyama H, Inada T, Matsuyama N, Kumano H . Interactions among a stressor, self-efficacy, coping with stress, depression, and anxiety in maintenance hemodialysis patients. Behav Med. 2004; 29(3):107-12. DOI: 10.1080/08964280309596063. View

Tuncel D, Orhan F, Sayarlioglu H, Isik I, Utku U, Dinc A . Restless legs syndrome in hemodialysis patients: association with depression and quality of life. Sleep Breath. 2010; 15(3):311-5. DOI: 10.1007/s11325-010-0382-z. View

Merlino G, Gigli G, Valente M . Sleep disturbances in dialysis patients. J Nephrol. 2008; 21 Suppl 13:S66-70. View

Allen R, Picchietti D, Hening W, Trenkwalder C, Walters A, Montplaisi J . Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4(2):101-19. DOI: 10.1016/s1389-9457(03)00010-8. View

Elder S, Pisoni R, Akizawa T, Fissell R, Andreucci V, Fukuhara S . Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2007; 23(3):998-1004. DOI: 10.1093/ndt/gfm630. View

Walsh M, Culleton B, Tonelli M, Manns B . A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 2005; 67(4):1500-8. DOI: 10.1111/j.1523-1755.2005.00228.x. View

Jaber B, Finkelstein F, Glickman J, Hull A, Kraus M, Leypoldt J . Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study. Am J Kidney Dis. 2008; 53(2):310-20. DOI: 10.1053/j.ajkd.2008.07.013. View

10.

Hays R, Martin S, Sesti A, Spritzer K . Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005; 6(1):41-4. DOI: 10.1016/j.sleep.2004.07.006. View

11.

Hening W, Allen R, Ondo W, Walters A, Winkelman J, Becker P . Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord. 2010; 25(11):1675-83. DOI: 10.1002/mds.23157. View

12.

Quilici S, Abrams K, Nicolas A, Martin M, Petit C, Lleu P . Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Sleep Med. 2008; 9(7):715-26. DOI: 10.1016/j.sleep.2007.11.020. View

13.

Trenkwalder C, Hundemer H, Lledo A, Swieca J, Polo O, Wetter T . Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology. 2004; 62(8):1391-7. DOI: 10.1212/01.wnl.0000124465.20878.84. View

14.

Walker S, Fine A, Kryger M . Sleep complaints are common in a dialysis unit. Am J Kidney Dis. 1995; 26(5):751-6. DOI: 10.1016/0272-6386(95)90438-7. View

15.

Walters A, LeBrocq C, Dhar A, Hening W, Rosen R, Allen R . Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003; 4(2):121-32. DOI: 10.1016/s1389-9457(02)00258-7. View

16.

Unruh M, Levey A, DAmbrosio C, Fink N, Powe N, Meyer K . Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am J Kidney Dis. 2004; 43(5):900-9. DOI: 10.1053/j.ajkd.2004.01.013. View

17.

Unruh M, Hartunian M, Chapman M, Jaber B . Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol. 2003; 59(4):280-8. DOI: 10.5414/cnp59280. View

18.

Reynolds J, Homel P, Cantey L, Evans E, Harding P, Gotch F . A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif. 2004; 22(3):320-8. DOI: 10.1159/000079186. View

19.

Abetz L, Arbuckle R, Allen R, Garcia-Borreguero D, Hening W, Walters A . The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting. Sleep Med. 2006; 7(4):340-9. DOI: 10.1016/j.sleep.2005.12.011. View

20.

Chertow G, Levin N, Beck G, Depner T, Eggers P, Gassman J . In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363(24):2287-300. PMC: 3042140. DOI: 10.1056/NEJMoa1001593. View